Neuroendocrine cancer of the cervix: Prognostic and predictive factors

Prognostic and Predictive Factors in Gynecologic Cancers

Volumn , Issue , 2007, Pages 307-324

  Chan, John K ^a   Kapp, Daniel S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957366939     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (85)

1. Albores-Saavedra J, Gersell D, Gilks CB, et al. Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 1997; 121: 34-9.
2. Sevin BU, Method MW, Nadji M, Lu Y, Averette HA. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 1996; 77: 1489-93.
3. Tateishi R, Wada A, Hayakawa K, Hongo J, Ishii S. Argyrophil cell carcinomas (apudomas) of the uterine cervix. Light and electron microscopic observations of 5 cases. Virchows Arch A Pathol Anat Histol 1975; 366: 257-74.
4. Albores-Saavedra J, Larraza O, Poucell S, Rodriguez Martinez HA. Carcinoid of the uterine cervix: additional observations on a new tumor entity. Cancer 1976; 38: 2328-42.
5. Akoun GM, Scarna HM, Milleron BJ, Benichou MP, Herman DP. Serum neuronspecific enolase. A marker for disease extent and response to therapy for small-cell lung cancer. Chest 1985; 87: 39-43.
6. Burghuber OC, Worofka B, Schernthaner G, et al. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 1990; 65: 1386-90.
7. Nakata SI, Yamamoto K, Kobayashi Y, et al. Excellent results of radiotherapy for neuroendocrine carcinoma of the uterine cervix. Oncol Rep 2001; 8: 777-9.
8. Chen CA, Wu CC, Juang GT, et al. Serum neuron-specific enolase levels in patients with small cell carcinoma of the uterine cervix. J Formos Med Assoc 1994; 93: 81-3.
9. Wistuba II, Thomas B, Behrens C, et al. Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol 1999; 72: 3-9.
10. Ishida GM, Kato N, Hayasaka T, et al. Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study. Int J Gynecol Pathol 2004; 23: 366-72.
11. Mannion C, Park WS, Man YG, et al. Endocrine tumors of the cervix: morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p, 3p, 11q, and 17p. Cancer 1998; 83: 1391-400.
12. Straughn JM Jr, Richter HE, Conner MG, Meleth S, Barnes MN. Predictors of outcome in small cell carcinoma of the cervix - a case series. Gynecol Oncol 2001; 83: 216-20.
13. Holm R, Abeler VM, Skomedal H, Nesland JM. Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri. Zentralbl Pathol 1993; 139: 153-6.
14. Ambros RA, Park JS, Shah KV, Kurman RJ. Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol 1991; 4: 586-93.
15. Miller B, Dockter M, El Torky M, Photopulos G. Small cell carcinoma of the cervix: a clinical and flow-cytometric study. Gynecol Oncol 1991; 42: 27-33.
16. Silva EG, Gershenson D, Sneige N, et al. Small cell carcinoma of the uterine cervix: pathology and prognostic factors. Surg Pathol 1989; 2: 105-15.
17. Ambros RA, Park JS, Shah KV, Kurman RJ. Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol 1991; 4: 586-93.
18. Stanley MA. Human papillomavirus (HPV) vaccines: prospects for eradicating cervical cancer. J Fam Plann Reprod Health Care 2004; 30: 213-15.
19. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802.
20. Pao CC, Lin CY, Chang YL, Tseng CJ, Hsueh S. Human papillomaviruses and small cell carcinoma of the uterine cervix. Gynecol Oncol 1991; 43: 206-10.
21. Wang HL, Lu DW. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol 2004; 28: 901-8.
22. Ohwada M, Wada T, Saga Y, et al. c-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix. Eur J Gynaecol Oncol 2006; 27: 53-5.
23. Shane JM, Naftolin F. Aberrant hormone activity by tumors of gynecologic importance. Am J Obstet Gynecol 1975; 121: 133-43.
24. Kiang DT, Bauer GE, Kennedy BJ. Immunoassayable insulin in carcinoma of the cervix associated with hypoglycemia. Cancer 1973; 31: 801-5.
25. Berthelot P, Benhamou JP, Fauvert R. [Hypercorticism and cancer of the uterus. Study of a case and review of the literature]. Presse Med 1961; 69: 1899-902.
26. Seckl MJ, Mulholland PJ, Bishop AE, et al. Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 1999; 341: 733-6.
27. McCusker ME, Cote TR, Clegg LX, Tavassoli FJ. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol 2003; 88: 333-9.
28. Viswanathan AN, Deavers MT, Jhingran A, et al. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 2004; 93: 27-33.
29. Reagan JW, Hamonic MJ, Wentz WB. Analytical study of the cells in cervical squamous- cell cancer. Lab Invest 1957; 6: 241-50.
30. van Nagell JR Jr, Powell DE, Gallion HH, et al. Small cell carcinoma of the uterine cervix. Cancer 1988; 62: 1586-93.
31. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 2003; 97: 568-74.
32. Bermudez A, Vighi S, Garcia A, Sardi J. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynecol Oncol 2001; 82: 32-9.
33. Chang TC, Lai CH, Tseng CJ, et al. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 1998; 83: 712-18.
34. Boruta DM 2nd, Schorge JO, Duska LA, et al. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 2001; 81: 82-7.
35. Hoskins PJ, Swenerton KD, Pike JA, et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involvedfield irradiation and platinum-based combination chemotherapy. J Clin Oncol 2003; 21: 3495-501.
36. Morris M, Gershenson DM, Eifel P, et al. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol 1992; 47: 62-5.
37. Stoler MH, Mills SE, Gersell DJ, Walker AN. Small-cell neuroendocrine carcinoma of the cervi. A human papillomavirus type 18-associated cancer. Am J Surg Pathol 1991; 15: 28-32.
38. Sheets EE, Berman ML, Hrountas CK, Liao SY, DiSaia PJ. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 1988; 71: 10-14.
39. Abeler VM, Holm R, Nesland JM, Kjorstad KE. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer 1994; 73: 672-7.
40. Sykes AJ, Shanks JH, Davidson SE. Small cell carcinoma of the uterine cervix: a clinicopathological review. Int J Oncol 1999; 14: 381-6.
41. Hoskins PJ, Wong F, Swenerton KD, et al. Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide. Gynecol Oncol 1995; 56: 218-25.
42. Ueoka H, Kiura K, Tabata M, et al. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up. Cancer 1998; 83: 283-90.
43. Fukuoka M, Furuse K, Saijo N, et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 1991; 83: 855-61.
44. Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992; 10: 282-91.
45. Lim P, Aquino-Parsons CF, Wong F, et al. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators. Gynecol Oncol 1999; 73: 191-5.
46. Kim YB, Barbuto D, Lagasse LD, Karlan BY. Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to regional lymph nodes. Gynecol Oncol 1996; 62: 411-14.
47. Delaloge S, Pautier P, Kerbrat P, et al. Neuroendocrine small cell carcinoma of the uterine cervix: What disease? What treatment? Report of ten cases and a review of the literature. Clin Oncol (R Coll Radiol) 2000; 12: 357-62.
48. O’Hanlan KA, Goldberg GL, Jones JG, et al. Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature. Gynecol Oncol 1991; 43: 167-72.
49. Lewandowski GS, Copeland LJ. A potential role for intensive chemotherapy in the treatment of small cell neuroendocrine tumors of the cervix. Gynecol Oncol 1993; 48: 127-31.
50. Weed JC, Shoup B, Tawfik O. Small cell carcinoma of the cervix: a clinical study of 15 patients and review of the literature. Prim Care Update Ob Gyns 1998; 5: 159.
51. Perrin L, Ward B. Small cell carcinoma of the cervix. Int J Gynecol Cancer 1995; 5: 200-3.
52. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341: 476-84.
53. Wistuba II, Gazdar AF, Minna JD. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001; 28(2 Suppl 4): 3-13.
54. Wang KL, Yang YC, Wang TY, et al. Neuroendocrine carcinoma of the uterine cervix: a clinicopathologic retrospective study of 31 cases with prognostic implications. J Chemother 2006; 18: 209-16.
55. Tsunoda S, Jobo T, Arai M, et al. Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases. Int J Gynecol Cancer 2005; 15: 295-300.
56. Masumoto N, Fujii T, Ishikawa M, et al. p16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol 2003; 34: 778-83.
57. Wang SJ, Wang MB, Calcaterra TC. Radiotherapy followed by neck dissection for small head and neck cancers with advanced cervical metastases. Ann Otol Rhinol Laryngol 1999; 108: 128-31.
58. Huang SF, Shueh S, Chang TC. Small cell carcinoma of the uterine cervix: pathologic analysis of 9 cases. Taiwan Yi Xue Hui Za Zhi 1988; 87: 297-303.
59. Walker AN, Mills SE, Taylor PT. Cervical neuroendocrine carcinoma: a clinical and light microscopic study of 14 cases. Int J Gynecol Pathol 1988; 7: 64-74.
60. Saul PB. The clinical management of small cell carcinoma of the cervix. In: Rutledge RF, Gershenson D, eds. Gynecologic Cancer. Austin: University of Texas Press, 1987: 245-250.
61. Barrett RJ 2nd, Davos I, Leuchter RS, Lagasse LD. Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix. Cancer 1987; 60: 2325-30.
62. Albores-Saavedra J, Larraza O, Poucell S, Rodriguez Martinez HA. Carcinoid of the uterine cervix: additional observations on a new tumor entity. Cancer 1976; 38: 2328-42.
63. Ueda G, Shimizu C, Shimizu H, et al. An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers. Gynecol Oncol 1989; 34: 164-9.
64. Ulich TR, Liao SY, Layfield L, et al. Endocrine and tumor differentiation markers in poorly differentiated small-cell carcinoids of the cervix and vagina. Arch Pathol Lab Med 1986; 110: 1054-7.
65. Groben P, Reddick R, Askin F. The pathologic spectrum of small cell carcinoma of the cervix. Int J Gynecol Pathol 1985; 4: 42-57.
66. Yamasaki M, Tateishi R, Hongo J, et al. Argyrophil small cell carcinomas of the uterine cervix. Int J Gynecol Pathol 1984; 3: 146-52.
67. Silva EC, Kott MM, Ordonez NG. Endocrine carcinoma intermediate cell type of the uterine cervix. Cancer 1984; 54: 1705-13.
68. Herrington CS, Graham D, Southern SA, Bramdev A, Chetty R. Loss of retinoblastoma protein expression is frequent in small cell neuroendocrine carcinoma of the cervix and is unrelated to HPV type. Hum Pathol 1999; 30: 906-10.
69. Hashi A, Yasumizu T, Yoda I, et al. A case of small cell carcinoma of the uterine cervix presenting Cushing’s syndrome. Gynecol Oncol 1996; 61: 427-31.
70. Iemura K, Sonoda T, Hayakawa A, et al. Small cell carcinoma of the uterine cervix showing Cushing’s syndrome caused by ectopic adrenocorticotropin hormone production. Jpn J Clin Oncol 1991; 21: 293-8.
71. Inoue T, Yamaguchi K, Suzuki H, Abe K, Chihara T. Production of immunoreactivepolypeptide hormones in cervical carcinoma. Cancer 1984; 53: 1509-14.
72. Lojek MA, Fer MF, Kasselberg AG, et al. Cushing’s syndrome with small cell carcinoma of the uterine cervix. Am J Med 1980; 69: 140-4.
73. Matsuyama M, Inoue T, Ariyoshi Y, et al. Argyrophil cell carcinoma of the uterine cervix with ectopic production of ACTH, β-MSH, serotonin, histamine, and amylase. Cancer 1979; 44: 1813-23.
74. Jones HW, Plymate S, Gluck FB, Miles PA, Greene JF. Small cell nonkeratinizing carcinoma of the cervix associated with ACTH production. Cancer 1976; 38: 1629-35.
75. Ishibashi-Ueda H, Imakita M, Yutani C, et al. Small cell carcinoma of the uterine cervix with syndrome of inappropriate antidiuretic hormone secretion. Mod Pathol 1996; 9: 397-400.
76. Kothe MJ, Prins JM, de Wit R, Velden KV, Schellekens PT. Small cell carcinoma of the cervix with inappropriate antidiuretic hormone secretion. Case report. Br J Obstet Gynaecol 1990; 97: 647-8.
77. Stockdale AD, Leader M, Phillips RH, Henry K. The carcinoid syndrome and multiple hormone secretion associated with a carcinoid tumour of the uterine cervix. Case report. Br J Obstet Gynaecol 1986; 93: 397-401.
78. Driessens J, Clay A, Adenis L, Demaille A. [Cervico-uterine tumor and biologic syndrome of carcinoidosis]. Arch Anat Pathol (Paris) 1964; 12: 200-3.
79. Sutton GP, Siemers E, Stehman FB, Ehrlich CE. Eaton-Lambert syndrome as a harbinger of recurrent small-cell carcinoma of the cervix with improvement after combination chemotherapy. Obstet Gynecol 1988; 72: 516-18.
80. Watanabe A, Wachi T, Omi H, et al. Granulocyte colony-stimulating factorproducing small-cell carcinoma of the uterine cervix: report of a case. Diagn Cytopathol 2000; 23: 269-74.
81. Lee NK, Nguyen S, Cheung MK, et al. Neuroendocrine small cell cervical carcinoma - an analysis of prognostic factors. Proceedings of Western Association of Gynecologic Oncologists, 2006.
82. Weed JC Jr, Graff AT, Shoup B, Tawfik O. Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg 2003; 197: 44-51.
83. Abeler VM, Holm R, Nesland JM, Kjorstad KE. Small cell carcinoma of the cervix. A clinical study of 26 patients. Cancer 1994; 73: 672-7.
84. Gersell DJ MG, Mutch DG, Rudloff MA. Small-cell undifferentiated carcinoma of the cervix. A clinicopathologic, ultrastructural, and immunocytochemical study of 15 cases. Am J Surg Pathol 1988; 12: 684-98.
85. Yu A, Zhang P, Lou H. Clinicopathologic characteristics and treatment of small cell carcinoma of uterine cervix. Zhonghua Zhong Liu Za Zhi 2002; 24: 400-3.